患有脑转移和预后不佳的患者的息护理和质量结果:多机构分析
Rohit Singh1,2, Camilo E Fadul3, Emily Kopp3
1Division of Hematology/Oncology, Department of Medicine, University of Vermont Medical Center, Burlington, VT.
JCO oncology practice
|February 23, 2026
概括
脑转移患者的息护理咨询增加了预先指示和临终关怀登记,但没有影响生存率. 在这群人群中,有大量未满足的息护理需求.
科学领域:
- 神经瘤学神经瘤学
- 抚慰性护理是一种缓解性护理.
- 提高质量 提高质量
背景情况:
- 大脑转移 (BMETs) 对预后不佳的患者构成复杂的挑战.
- 息治疗 (PC) 旨在改善患有严重疾病的患者的生活质量.
- 在BMET中了解PC咨询模式对于优化护理至关重要.
研究的目的:
- 分析脑转移 (BMETs) 患者的息护理 (PC) 咨询模式.
- 评估PC咨询与治疗,整体存活率 (OS) 和质量指标 (如预先指令 (ADs) 和住院招生) 的关联.
主要方法:
- 在2017年至2019年间对被诊断患有BMET的患者进行了多机构的后期质量评估.
- 收集的数据包括人口统计,癌症诊断,表现状况,治疗,PC咨询和生存率.
- 被纳入的患者预计生存时间小于1年 (U-RPA类2B和3).
主要成果:
- 在487名符合条件的BMET患者中,56%接受了PC咨询.
- PC咨询没有改变接受癌症导向治疗或最佳支持性护理 (BSC) 的可能性.
- 在PC患者中,记录的预先指示 (ADs) 和住院招生率显著更高 (P < .0001).
结论:
- 在BMETs中的息护理参与与更好的预先指令完成和临终关怀利用相关.
- 专家咨询没有影响生存或显著改变治疗选择.
- 在高风险的大脑转移患者中,人们对息护理服务的需求尚未得到满足.
相关概念视频
01:21Cancer Survival Analysis
796
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
796
01:24Kaplan-Meier Approach
657
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
657
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K